Proprietary non-animal stabilized hyaluronic acid/dextranomer gel (NASHA/Dx) for endoscopic treatment of grade IV vesicoureteral reflux: Long-term observational study
Authors:
Open Access
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 16 (3) , 328.e1-328.e9
Abstract
No abstract availableKeywords
Funding Information
- Palette Life Sciences and the Gillberg Foundation for Scientific Research
This publication has 47 references indexed in Scilit:
- Results of Treatment of Grades IV and V Vesicoureteral Reflux with Endoscopic Injection of Polyacrylate Polyalcohol CopolymerFrontiers in Pediatrics, 2013
- Efficacy of Hydrodistention Implantation Technique in Treating High-Grade Vesicoureteral RefluxKorean Journal of Urology, 2012
- Vesicoureteral Reflux and Reflux NephropathyAdvances in Chronic Kidney Disease, 2011
- Surgical management of vesicoureteral reflux in childrenPediatric Nephrology, 2011
- Endoscopic treatment of vesicoureteral reflux: current practice and the need for multifactorial assessmentTherapeutic Advances in Urology, 2009
- Endoscopic treatment of vesicoureteral reflux: Current statusIndian Journal of Urology, 2009
- Injection therapy: Advancing the treatment of vesicoureteral refluxJournal of Pediatric Urology, 2006
- Minimally Invasive Treatment of Vesicoureteral Reflux with Endoscopic Injection of Dextranomer/Hyaluronic Acid Copolymer: The Children’s Hospitals of Atlanta ExperienceJournal of Urology, 2003
- Spontaneous Resolution of Vesicoureteral Reflux: A 15-Year PerspectiveJournal of Urology, 2002
- Vesico‐ureteric reflux: occurrence and long‐term risksActa Paediatrica, 1999